Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | GPR27 | Q9NS67 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | CASP1 | P29466 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.35 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.35 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.35 |
| ▸ | AHR | P35869 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL103521 | 0.89 | ALDH1A1 (0.44) | MAPK1TSHRALDH1A1ALOX15KMT2A | |
| SCHEMBL7707415 | 0.81 | ALDH1A1 (0.54) | CYP3A4MAPK1TSHRALDH1A1ALOX15 | |
| SCHEMBL9197919 | 0.81 | ALDH1A1 (0.48) | CYP3A4MAPK1TSHRALDH1A1ALOX15 | |
| SCHEMBL29886586 | 0.80 | TSHR (0.64) | CYP3A4MAPK1TSHRALDH1A1ALOX15 | |
| SCHEMBL432644 | 0.80 | TSHR (0.64) | CYP3A4MAPK1TSHRALDH1A1ALOX15 | |
| SCHEMBL4452322 | 0.80 | MAPK1 (0.44) | CYP3A4MAPK1TSHRALDH1A1KMT2A | |
| SCHEMBL7938468 | 0.79 | ALDH1A1 (0.43) | CYP3A4MAPK1TSHRALDH1A1ALOX15 | |
| SCHEMBL29205053 | 0.79 | TSHR (0.38) | CYP3A4MAPK1TSHRALDH1A1ALOX15 | |
| SCHEMBL106507 | 0.79 | HPGD (0.44) | TSHRALDH1A1ALOX15KMT2AATM | |
| SCHEMBL10625935 | 0.79 | ALDH1A1 (0.37) | CYP3A4TSHRALDH1A1ALOX15KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 504 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116874640-A | Long-residence sodium hyaluronate derivative for hair repair and preparation method thereof | 江南大学 | 2023-10-13 | — | — | CN | claimed |
| CN-116178301-A | Preparation method of cyclic lipopeptides natural product Dysoxyactam A and analogues thereof | 中国科学院上海药物研究所 | 2023-05-30 | — | — | CN | claimed |
| WO-2020230037-A1 | ALTERNATE PROCESS FOR THE PREPARATION OF ENCEQUIDAR | DR. REDDY'S LABORATORIES LIMITED (IN) | 2020-11-19 | — | — | WO | claimed |
| CN-106674252-B | The fluoroolefin of marine natural products cyclic ester peptide. is similar to object, preparation method and use | FUDAN UNIVERSITY (CN) | 2019-10-29 | — | — | CN | claimed |
| CN-110117293-A | Mostly fluorine-substituted Largazole analog, preparation method and use | 复旦大学 | 2019-08-13 | — | — | CN | claimed |
| CN-105617379-B | A kind of Nano medication delivery system and the preparation method and application thereof of ROS response | 上海交通大学 | 2018-12-25 | — | — | CN | claimed |
| CN-108948045-A | A kind of preparation method of tesirolimus | 鲁南制药集团股份有限公司 | 2018-12-07 | — | — | CN | claimed |
| EP-3071602-B1 | NANOFIBERS CONTAINING PHOTOCURABLE ESTER DERIVATIVE OF HYALURONIC ACID OR ITS SALT, PHOTOCURED NANOFIBERS, METHOD OF SYNTHESIS THEREOF, PREPARATION CONTAINING PHOTOCURED NANOFIBERS AND USE THEREOF | CONTIPRO AS (CZ) | 2017-08-23 | — | — | EP | claimed |
| CN-106674330-A | 34-Dimethyl apratoxin A/E preparation method | 复旦大学 | 2017-05-17 | — | — | CN | claimed |
| CN-106674252-A | Fluorinated olefin analogue of marine natural product cyclic depsipeptide as well as preparation method and application of fluorinated olefin analogue | 复旦大学 | 2017-05-17 | — | — | CN | claimed |
| EP-1328527-A1 | CEPHALOTAXANES, THEIR METHOD OF PREPARATION AND THEIR USE IN TREATMENT OF CANCERS, LEUKEMIAS, PARASITES INCLUDING THOSE RESISTANT TO USUAL CHEMOTHERAPEUTIC AGENTS AND AS REVERSAL AGENTS | Oncopharm Corporation (US) | 2003-07-23 | — | — | EP | claimed |
| WO-2002032904-A1 | NEW CEPHALOTAXANES, THEIR METHOD OF PREPARATION AND THEIR USE IN TREATMENT OF CANCERS, LEUKEMIAS, PARASITES INCLUDING THUS RESISTANT TO USUAL CHEMOTHERAPEUTIC AGENTS AND AS REVERSAL AGENTS | ONCOPHARM CORPORATION (FR) | 2002-04-25 | — | — | WO | claimed |
| CN-1300289-A | Novel cephalotaxane derivatives and process for preparing same | ONCOPHARM CORP (US) | 2001-06-20 | — | — | CN | claimed |
| US-6093812-A | LACTAMIZATION OF A 2-HYDROXYALKYLAMIDE IN AQUEOUS SOLUTION BY TREATMENT WITH A POLYCHLOROBENZOYL CHLORIDE, BASE AND PHASE TRANSFER AGENT | SCHERING CORPORATION (US) | 2000-07-25 | — | — | US | claimed |
| EP-0596015-B1 | SUBSTITUTED BETA-LACTAM COMPOUNDS USEFUL AS HYPOCHOLESTEROLEMIC AGENTS AND PROCESSES FOR THE PREPARATION THEREOF | SCHERING CORP (US) | 1997-10-01 | — | — | EP | claimed |
| CN-1143641-A | Novel process for the preparation of taxanes using oxazolidine intermediates | BRISTOL MYERS SQUIBB CO (US) | 1997-02-26 | — | — | CN | claimed |
| CN-1094725-A | Process for preparing taxanes with side chain and intermediates thereof | BRISTOL MYERS SQIBB COMPANY (US) | 1994-11-09 | — | — | CN | claimed |
| EP-0596015-A1 | SUBSTITUTED BETA-LACTAM COMPOUNDS USEFUL AS HYPOCHOLESTEROLEMIC AGENTS AND PROCESSES FOR THE PREPARATION THEREOF. | SCHERING CORP (US) | 1994-05-11 | — | — | EP | claimed |
| WO-1993002048-A1 | SUBSTITUTED BETA-LACTAM COMPOUNDS USEFUL AS HYPOCHOLESTEROLEMIC AGENTS AND PROCESSES FOR THE PREPARATION THEREOF | SCHERING CORPORATION (US) | 1993-02-04 | — | — | WO | claimed |
| EP-0524595-A1 | Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for the preparation thereof | SCHERING CORPORATION (US) | 1993-01-27 | — | — | EP | claimed |